OK, Fine: NYC Isn't Great For Startups (Yet), But It's Going To Be
Business Insider, Silicon Valley Insider
Warren Lee’s thoughts as well as what a top angel investor and a few successful local entrepreneurs have to say about the NYC startup scene…
Cubist to Acquire Calixa Therapeutics in Deal Worth up to $402.5M
Cubist hopes to have its purchase of Calixa wrapped up by the end of 2009...
Cylex™ CEO Presides Over NASDAQ Closing Bell Ceremony
Prestigious Business Honor Based on National Fast Growth Recognition for Global Life Sciences Company...
Newly Formed Durata Therapeutics Acquires Pfizer's Vicuron Subsidiary
Durata is focused primarily on Vicuron’s antibiotic drug candidate, dalbavancin...
SXSW: DRINKs on ME
We want to know what you're into - and we want to buy you drinks while you tell us. Drinks on us @ SXSW. ...
In Their Own Words: Canaan Partners’ Wende Hutton Optimistic But Wary Of The FDA (WSJ Blogs)
We asked a number of venture capital investors to answer four questions...
YourStory Exclusive: Sharad Sharma shares his pearls of wisdom and experience
...
Canaan Partners Closes $650 Million Fund, Canaan VIII
Global Firm Marks 20th Anniversary With Closing of 8th Fund Bringing Capital Under Management to $3B...
